Lost your password?

Blogs about: Revlimid

Featured Blog

Log of the OPTIMIST #69 September 22, 20099 comments

suecantrell wrote 3 months ago: Ahoy, Mateys! Well, I’ve alternated between being anxious to write this, after my appointment a week … more →

Tags: fatigue, myeloma, stamina

Log of the OPTIMIST #66 June 29th, 2009 (Monday)

cantrellryan wrote 5 months ago: Ahoy! Well, the FedEx guy has delivered the “Poison pills” for the next 3 weeks and I’m loaded with … more →

Tags: myeloma, er, hospital, YMCA, Adriatic Coast

Log of the OPTIMIST #65 June 1, 20091 comment

cantrellryan wrote 5 months ago: Ahoy Mateys! Anchors aweigh! Tomorrow morning the gangplank comes up and we’re off on our new voyage … more →

Tags: chemo, desamethasone, MMRF, Multiple Myeloma, steroid, Travel

REMS and Generics -- Like Oil and Water1 comment

Jeremy G wrote 6 months ago: A great post from Michael McCaughan at the In Vivo Blog walks through the very complicated interacti … more →

Tags: Jeremy Grushcow, FDAAA, Generics, In Vivo Blog, rem's, Risk Evaluation and Mitigation Strategies, dr reddys, FDA Amendments Act

Study Of Revlimid And Vidaza In Higher-Risk MDS Is Well-Tolerated And Has High Activity

healtherm2 wrote 11 months ago: Celgene International Sarl (NASDAQ: CELG) reported that results of a Phase I study combining REVLIMI … more →

Tags: Med News, study, high, activity, Higher-Risk, Vidaza, Well-Tolerated

Wall Street Analysts cheer Millenium Pharma

danielteper wrote 1 year ago:   Millenium Pharmaceuticals (NASDAQ:MLNM) is a new favorite among Wall Street Analysts. The favorabl … more →

Tags: Investors, Equities, Oncology, Velcade, Celgene, Millenium Pharma, Biotech Stock, Johnson & Johnson, JP Morgan Healthcare Conference

Clinical Cancer Advances 20071 comment

danielteper wrote 2 years ago: The American Society of Clinical Oncology (ASCO) conducted its annual independant review and publish … more →

Tags: Oncology, Avastin, novartis, ImClone, Velcade, Oncology Drug Pipeline, Asco, Nexavar, Torisel

Pharma News 12_17

Steve Woodruff wrote 2 years ago: Some interesting oncology results: Millennium’s Velcade used in combo therapy for multiple mye … more →

Tags: Pharmaceutical, Biotech, Pharma News, GlaxoSmithKline, GSK, jj, Forest Labs, novartis, AstraZeneca

Pharma News 11_30

Steve Woodruff wrote 2 years ago: Glaxo buying Reliant - GlaxoSmithKline Plc has agreed to buy privately held heart drug specialist Re … more →

Tags: Pharma, Pharmaceutical, Biotech, Medical Devices, Pharma News, Oncology, GlaxoSmithKline, GSK, jj


Related Tags
All →

Follow this tag via RSS